Effect of Hemp-CBD on Patients With CIPN
Conditions: Chemotherapy-induced Peripheral Neuropathy; Colorectal Cancer Stage II; Colorectal Cancer Stage III; Breast Cancer; Ovarian Cancer Interventions: Drug: Hemp-based CBD; Other: Placebo oral tablet Sponsors: Main Line Health; Ananda Hemp, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2020 Category: Research Source Type: clinical trials
A double-blind, randomized, crossover trial protocol of whole hemp seed protein and hemp seed protein hydrolysate consumption for hypertension
This study will be the first trial investigating the potential anti-hypertensive benefit of dietary hemp protein plus bioactive peptide consumption in humans.Trial registrationNational Clinical Trial (NCT), ID:NCT03508895. Registered on 28 June 2018. Retrospectively registered on the publicly accessible Registry Databank at ClinicalTrials.gov (http://ClinicalTrials.gov). (Source: Trials)
Source: Trials - April 22, 2020 Category: Research Source Type: clinical trials
The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC)
Conditions: Interstitial Cystitis; Bladder Pain Syndrome Interventions: Drug: Cannabidiol vaginal suppository; Drug: Placebo vaginal suppository Sponsor: University of New Mexico Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2020 Category: Research Source Type: clinical trials
